A detailed history of Interchange Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Interchange Capital Partners, LLC holds 11,793 shares of MRK stock, worth $1.17 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares
11,793
Previous 11,975 1.52%
Holding current value
$1.17 Million
Previous $1.48 Million 9.65%
% of portfolio
0.48%
Previous 0.55%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$111.15 - $128.97 $20,229 - $23,472
-182 Reduced 1.52%
11,793 $1.34 Million
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $1.23 Million - $1.32 Million
9,936 Added 487.3%
11,975 $1.48 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $10,531 - $12,271
93 Added 4.78%
2,039 $269,000
Q4 2023

Jan 09, 2024

SELL
$100.18 - $109.02 $73,932 - $80,456
-738 Reduced 27.5%
1,946 $212,000
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $97,390 - $108,156
-946 Reduced 26.06%
2,684 $276,000
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $827,173 - $901,582
-7,616 Reduced 67.72%
3,630 $418,000
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $1.16 Million - $1.29 Million
11,246 New
11,246 $1.2 Million
Q4 2021

Feb 04, 2022

SELL
$72.28 - $90.54 $759,662 - $951,575
-10,510 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $37,345 - $41,070
-521 Reduced 4.72%
10,510 $789,000
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $170,853 - $188,981
-2,430 Reduced 18.05%
11,031 $857,000
Q1 2021

May 05, 2021

SELL
$68.86 - $81.11 $30,642 - $36,093
-445 Reduced 3.2%
13,461 $1.04 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $998,033 - $1.11 Million
13,906 New
13,906 $1.14 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Interchange Capital Partners, LLC Portfolio

Follow Interchange Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Interchange Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Interchange Capital Partners, LLC with notifications on news.